By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Gout is one of the oldest documented human illnesses. It develops when sharp crystals form inside joints, triggering intense swelling and pain, and is ...
21hon MSNOpinion
Ethics should lead, not play catch-up, expert emphasizes as Japan panel OKs making human embryos from stem cells
A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after ...
Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...
Ecuadorian scientists have, for the first time, edited the gene of a fungus that destroys banana plantations. Using an ...
Cacao yields in West Africa are collapsing by up to 40% due to drought and climate stress. These conditions have driven the steepest price increases for cacao in recorded history, destabilising the ...
Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...
The N-glycans attached to the Fc region of immunoglobulin G (IgG) contain combinations of core fucose, bisecting GlcNAc, galactose, and sialic acid; variations in these monosaccharides - regulated ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +11.36% and -86.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results